Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

Liver Is Life 螢幕截圖

iPad

iPhone

About Liver Is Life

**First ever full version Augmented reality app replicating a Human Liver**,
India’s first ever 3D Liver App! Free of cost, easy to navigate and user friendly!

This free app enables Health Care Practitioners (HCPs) to educate the patients on different stages of liver diseases with the help of a printed marker.
The prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) in India is around 9-35%¹. Globally liver disease is one of the leading causes of death.

- First of its kind innovative in clinic awareness tool
- Facilitates doctor patient interaction on NAFLD and enhances interest in the same
- Enables HCPs to guide patients on early detection, diagnosis and management of NAFLD

- Prevents the disease progression and enables the patients to live a healthy and happy life

This app is meant for HCPs and works only by scanning the Marker given by Abbott India Limited representatives to doctors.
Contact Abbott India Limited representative (WH & GI Team) to get the marker for the app to function.

¹ Duseja A, et al. Non-alcoholic Fatty Liver Disease and Metabolic Syndrome—Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology. J CLIN EXP HEPATOL 2015;5(1):51–68